Skip to content
Search

Latest Stories

Submit Guest Post

India and US collaborating on combating COVID-19: Taranjit Singh Sandhu

INDIA and the US are working together on combating the deadly coronavirus and collaboration is underway in the areas of diagnostics and therapeutics of the disease, said Indian envoy.

"In the present context of COVID-19 pandemic, close collaboration in the areas of diagnostics and therapeutics of the disease is underway,” India's Ambassador to the US, Taranjit Singh Sandhu said.


"India and the US have had a long-standing productive partnership in the healthcare sector, especially between the research institutions and industries of both countries,” he said.

Under the existing bilateral collaboration in healthcare sector- the National Institute of Allergy and Infectious Disease in the US shared the important reagents with the Translational Health Science Technology Institute in Gurgaon, India.

Besides, India-based vendors of American companies are in touch with the Indian Council of Medical Research to engage and enhance the capabilities for COVID-19 test in India.

The Center for Disease Control (CDC) in US has helped India in implementing a surveillance system in 35 hospitals and 22 states for healthcare associated infections.

It has evaluated 346 laboratory facilities across the country to identify needs and trained more than 1,700 laboratorians on quality diagnostic testing/reporting of priority diseases.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cancer treatment

The NHS availability announced in September 2026 applies to eligible patients in England. The treatment has already been available in Scotland for more than two years.

What is Enhertu and how could the new NHS breast cancer treatment help patients?

Highlights:
  • Enhertu is a targeted treatment for certain HER2-low breast cancers.
  • It is available for around 1,000 women in England.
  • The drug can extend survival compared with chemotherapy.
  • NICE initially rejected widespread NHS use in 2024.
  • The decision was reversed after a commercial agreement was reached.

Breast cancer treatment continues to evolve as researchers develop therapies aimed at specific characteristics of cancer cells. One such treatment is Enhertu, which has now become available on the NHS in England for people with a particular type of advanced breast cancer.

The treatment is intended for patients with HER2-low breast cancer that cannot be removed through surgery or has spread to other parts of the body. This is known as metastatic breast cancer. According to the latest announcement, around 1,000 women in England will be eligible for the treatment.

Keep ReadingShow less